The Children's Place, Inc. (PLCE) confirmed earnings release on September 04, 2026, After the market for the quarter ending August 02, 2026.The estimated EPS is $-0.90037The estimated revenue is $270767600 Price Impact of Stock Earnings Earnings Surprise Potential: If the actual earnings exceed market expectations, it could trigger a positive response from investors, leading to...
KNOT Offshore Partners LP (KNOP) confirmed earnings release on September 04, 2026, Before the market for...
Virco Mfg. Corporation (VIRC) confirmed earnings release on September 04, 2026, Before the market for the...
Hurco Companies, Inc. (HURC) confirmed earnings release on September 04, 2026, Before the market for the...
eGain Corporation (EGAN) confirmed earnings release on September 03, 2026, After the market for the quarter...
Dana Telsey from Telsey Advisory issued a price target of $18.00 for JILL on 2026-09-03 13:46:04.The adjusted price target was set to $18.00.At the time of the announcement, JILL was...
Boobalan Pachaiyappan from Roth Capital issued a price target of $8.00 for OVID on 2026-09-03 12:01:48.The adjusted price target was set to $8.00.At the time of the announcement, OVID was...
Alpha Tau to from Barclays issued a price target of $30.00 for DRTS on 2026-09-03 09:54:22.The adjusted price target was set to $30.00.At the time of the announcement, DRTS was...
Laurence Alexander from Jefferies issued a price target of $26.00 for IPX on 2026-09-02 07:39:00.The adjusted price target was set to $26.00.At the time of the announcement, IPX was trading...
from Raymond James issued a price target of $87.00 for CHMG on 2026-09-01 20:15:15.The adjusted price target was set to $87.00.At the time of the announcement, CHMG was trading at...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
